Zdrowie i gospodarka · 21/11/2003

FDA Releases Updated Guidance on Stability Testing for Pharmaceuticals in Harsh Climates

The Food and Drug Administration (FDA) has made two updated guidances available, including a revised version of the Q1A guidance on stability testing for new drug substances and products, and a new Q1F guidance on stability data packages for registration applications in extreme climates.